To the full analysis
Savencia stock: growth
SAVE.PASavencia reported $7.71B in revenue for fiscal 2025, down 2.6% on the prior year, up 6.2% a year on average over up to five years.
Daily figure as of 13 Nov 2026
Revenue (Annual rate)
3.9%
per year from 2006 to 2025, per share 4.3%
Earnings (Annual rate)
−2.1%
per year from 2006 to 2025, per share −1.4%
Free cash flow (Annual rate)
−2.8%
per year from 2006 to 2025, per share −2.5%
Growth per year by period
What reaches shareholders is growth per share: buybacks lift it, new shares dilute it.
| since 2020 | since 2015 | since 2006 | |
|---|---|---|---|
| Revenue | 6.2% | 4.6% | 3.9% |
| Revenue per share | 5.8% | 4.6% | 4.3% |
| Earnings | −1.1% | 2.7% | −2.1% |
| Earnings per share | 0.0% | 3.5% | −1.4% |
| Free cash flow | −20.4% | −2.6% | −2.8% |
| Free cash flow per share | −20.7% | −2.6% | −2.5% |
Fiscal years at a glance
How revenue and earnings grow
- Revenue
- Earnings
- Free cash flow
Figures as a table
| Year | Revenue | Earnings | Free cash flow |
|---|---|---|---|
| 2006 | $3.7B | $124.2M | $112.69M |
| 2007 | $3.79B | $179.13M | $16.32M |
| 2008 | $3.94B | $42.08M | $36.92M |
| 2009 | $3.63B | $49.3M | $162.49M |
| 2010 | $3.96B | $90.19M | −$52.44M |
| 2011 | $4.41B | $48.33M | $32.77M |
| 2012 | $4.53B | $71.09M | $74.15M |
| 2013 | $4.66B | $54.18M | −$80.77M |
| 2014 | $5.1B | $43.95M | −$51.16M |
| 2015 | $4.92B | $63.18M | $85.4M |
| 2016 | $4.9B | $115.79M | $39.88M |
| 2017 | $5.38B | $103.04M | −$27.65M |
| 2018 | $5.39B | $60.75M | $31.6M |
| 2019 | $5.55B | $81.56M | $34.35M |
| 2020 | $5.72B | $87.33M | $206.24M |
| 2021 | $6.22B | $91.9M | $80.19M |
| 2022 | $7.26B | $75.4M | $73.86M |
| 2023 | $7.52B | $106.91M | $90.53M |
| 2024 | $7.91B | $118.53M | $153.77M |
| 2025 | $7.71B | $82.78M | $65.87M |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Currency
- Amounts in US dollars, converted at the ECB reference rate of 12 Nov 2026 ($1 = €0.9024)
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Neutral, published since 7 Nov 2026 (in the score history since 18 Oct 2026)
- Valuation signal Undervalued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.